Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000222088 | SCV000270975 | likely benign | not specified | 2015-06-04 | criteria provided, single submitter | clinical testing | p.Thr4043Met in exon 51 of TTN: This variant is not expected to have clinical si gnificance because it has been identified in 0.3% (33/9780) of African chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs148551876). |
Invitae | RCV000560779 | SCV000642714 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000222088 | SCV000701150 | likely benign | not specified | 2016-11-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000222088 | SCV000730337 | likely benign | not specified | 2017-12-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000222088 | SCV001426793 | benign | not specified | 2020-07-13 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.12128C>T (p.Thr4043Met) results in a non-conservative amino acid change located in the I-band region of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 248540 control chromosomes, predominantly at a frequency of 0.0036 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 6-fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Cardiomyopathy phenotype (0.00063), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.12128C>T has been reported in the literature in a pediatric patient affected with Dilated Cardiomyopathy who also carried a PKP2 pathogenic variant (c.663C>A, p.Y221X; Headrick_2019). This report does not provide unequivocal conclusions about association of the variant with Cardiomyopathy. An additional co-occurrence with a pathogenic variant has been reported via internal testing (TTR c.424G>A, p.Val142Ile). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Genome- |
RCV001840333 | SCV002100055 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840334 | SCV002100057 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840335 | SCV002100058 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840332 | SCV002100059 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003937844 | SCV004755379 | likely benign | TTN-related condition | 2020-03-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |